Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wolf, Denise M ^a   Lenburg, Marc E ^b   Yau, Christina ^a,c   Boudreau, Aaron ^a   Van't Veer, Laura J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; HISTONE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER PROGNOSIS; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE CLUSTER; GENE CO EXPRESSION MODULE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; METASTASIS; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; BREAST TUMOR; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; PATHOLOGY; PROGNOSIS;

BREAST NEOPLASMS; CLUSTER ANALYSIS; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84895739525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088309     Document Type: Article

References (54)

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
2. Prat A, Parker JS, Karginova O, Fan C, Livasy C, et al. (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Research 12.
3. TCGA-network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
4. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352.
5. Hartwell LH, Hopfield JJ, Leibler S, Murray AW (1999) From molecular to modular cell biology. Nature 402: C47-52.
6. Wolf DM, Arkin AP (2003) Motifs, modules and games in bacteria. Curr Opin Microbiol 6: 125-134. (Pubitemid 36628655)
7. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70. (Pubitemid 30046295)
8. Hanahan D,Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
9. Segal E, Friedman N, Koller D, Regev A (2004) A module map showing conditional activity of expression modules in cancer. Nat Genet 36: 1090-1098. (Pubitemid 41184471)
10. Xu Y, Duanmu H, Chang Z, Zhang S, Li Z, et al. (2012) The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer. Mol Biol Rep 39: 1627-1637.
11. Sun S, Dong X, Fu Y, Tian W (2012) An iterative network partition algorithm for accurate identification of dense network modules. Nucleic Acids Research 40: e18.
12. Shi Z, Derow CK, Zhang B (2010) Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression. BMC Syst Biol 4: 74.
13. Buness A, Kuner R, Ruschhaupt M, Poustka A, Sultmann H, et al. (2007) Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer. Bioinformatics 23: 2273-2280. (Pubitemid 47423865)
14. Bessarabova M, Kirillov E, Shi WW, Bugrim A, Nikolsky Y, et al. (2010) Bimodal gene expression patterns in breast cancer. BMC Genomics 11.
15. Mentzen WI, Floris M, de la Fuente A (2009) Dissecting the dynamics of dysregulation of cellular processes in mouse mammary gland tumor. Bmc Genomics 10: 601.
16. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, et al. (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Research 10: R65.
17. Zhang J, Lu K, Xiang Y, Islam M, Kotian S, et al. (2012) Weighted frequent gene co-expression network mining to identify genes involved in genome stability. PLoS Comput Biol 8: e1002656.
18. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527. (Pubitemid 44854747)
19. Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, et al. (2008) Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clinical Cancer Research 14: 5158-5165.
20. Teschendorff AE, Caldas C (2008) A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer. Breast Cancer Research 10: R73.
21. Hu ZY, Fan C, Oh DS, Marron JS, He XP, et al. (2006) The molecular portraits of breast tumors are conserved across microarray platforms. Bmc Genomics 7.
22. Palmer C, Diehn M, Alizadeh AA, Brown PO (2006) Cell-type specific gene expression profiles of leukocytes in human peripheral blood. Bmc Genomics 7: 115.
23. Liu Y, Hayes DN, Nobel A, Marron JS (2008) Statistical Significance of Clustering for High-Dimension, Low-Sample Size Data. Journal of the American Statistical Association 103: 1281-1293.
24. Huang H, Liu Y, Yuan M, Marron JS (2013) Statistical Significance of Clustering using Soft Thresholding. Cornell University Library.
25. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 4: 44-57.
26. Reimand J, Arak T, Vilo J (2011) g:Profiler-a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Research 39: W307-315.
27. Sutherland RL (2011) Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4. Breast Cancer Research 13: 106.
28. Sabine VS, Sims AH, Macaskill EJ, Renshaw L, Thomas JS, et al. (2010) Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer. Breast Cancer Res Treat 122: 419-428.
29. Nagalla S, Chou JW, Willingham MC, Ruiz J, Vaughn JP, et al. (2013) Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol 14: R34.
30. Andre F, Dieci MV, Dubsky P, Sotiriou C, Curigliano G, et al. (2013) Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer. Clin Cancer Res 19: 28-33.
31. Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, et al. (2010) A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer. Breast Cancer Res 12: R85.
32. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27: 1160-1167.
33. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536. (Pubitemid 34130608)
34. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. New England Journal of Medicine 351: 2817-2826. (Pubitemid 40051905)
35. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DSA, et al. (2006) Concordance among gene-expression-based predictors for breast cancer. New England Journal of Medicine 355: 560-569. (Pubitemid 44200649)
36. Bergamaschi A, Tagliabue E, Sorlie T, Naurne B, Triulzi T, et al. (2008) Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. Journal of Pathology 214: 357-367. (Pubitemid 351212391)
37. Tutt A, Wang A, Rowland C, Gillett C, Lau K, et al. (2008) Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature. Bmc Cancer 8.
38. Nelson CM, Bissell MJ (2006) Of extracellular matrix, scaffolds, and signaling: Tissue architecture regulates development, homeostasis, and cancer. Annual Review of Cell and Developmental Biology 22: 287-309.
39. Esserman LJ, Berry DA, Cheang MC, Yau C, Perou CM, et al. (2012) Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat 132: 1049-1062.
40. Iwamoto T, Bianchini G, Booser D, Qi Y, Coutant C, et al. (2011) Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J Natl Cancer Inst 103: 264-272.
41. Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. International Journal of Cancer 128: 2527-2535.
42. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009.
43. Xu R, Boudreau A, Bissell MJ (2009) Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev 28: 167-176.
44. Cheng WY, Ou Yang TH, Anastassiou D (2013) Development of a prognostic model for breast cancer survival in an open challenge environment. Sci Transl Med 5: 181ra150.
45. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of affymetrix GeneChip probe level data. Nucleic Acids Research 31.
46. Dai MH, Wang PL, Boyd AD, Kostov G, Athey B, et al. (2005) Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Research 33.
47. Spira A, Beane JE, Shah V, Steiling K, Liu G, et al. (2007) Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 13: 361-366. (Pubitemid 46376687)
48. Fraley C, Raftery AE (2006, revised 2010) MCLUST Version 3 for R: Normal Mixture Modeling and Model-Based Clustering. Department of Statistics, University of Washington.
49. Wang J, Wen S, Symmans WF, Pusztai L, Coombes KR (2009) The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data. Cancer Inform 7: 199-216.
50. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
51. Schwarz GE (1978) Estimating the diension of a model. Annals of Statistics 6: 461-464.
52. Boersma BJ, Reimers M, Yi M, Ludwig JA, Luke BT, et al. (2008) A stromal gene signature associated with inflammatory breast cancer. International Journal of Cancer 122: 1324-1332. (Pubitemid 351287233)
53. Therneau T (2012) A Package for Survival Analysis in S. R package version 2.36-14.
54. R Development Core Team (2010) R: A language and environment for statisical computing. Vienna, Austria.